2024-11-06 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis

**1. Performance Analysis:**

UnitedHealth Group Inc. (UNH) is one of the largest health insurance companies in the United States. The company provides a wide range of health insurance plans, as well as healthcare services, to individuals and businesses.

UNH has significantly outperformed the S&P 500 (VOO) with a cumulative return of 285.97% compared to VOO's 134.06%.  This represents a **151.91 point** difference.  This outperformance has been consistent over the past several years, with UNH consistently exceeding VOO by a wide margin. The company's **alpha** has consistently been positive and has generally outperformed the S&P 500, indicating strong stock performance relative to market benchmarks. This reinforces the idea that UNH is a strong performer in the healthcare sector. 

**Alpha, Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|------|------|-----|-------|------|
| 2015-2017 | 118.8% | 12.4% | 88.6% | 0.9 |
| 2016-2018 | 113.9% | 18.6% | 89.2% | 0.9 |
| 2017-2019 | 82.1% | 23.3% | 39.0% | 0.9 |
| 2018-2020 | 58.6% | 36.0% | 19.5% | 1.1 |
| 2019-2021 | 106.2% | 36.0% | 16.4% | 1.0 |
| 2020-2022 | 81.3% | 36.0% | 63.5% | 0.9 |
| 2021-2023 | 50.6% | 18.3% | 21.8% | 0.5 |
| 2022-2024 | 12.9% | 20.0% | -7.8% | 0.4 |

The company's beta has been generally below 1, implying that it is less volatile than the overall market. However, it is worth noting that the beta has decreased in recent years, suggesting a potential decrease in volatility.

**2. Recent Price Movements:**

* Closing price: 567.03
* 5-day Moving Average: 563.96
* 20-day Moving Average: 571.71
* 60-day Moving Average: 580.71

The current price is slightly below the 5-day and 20-day moving averages, indicating potential short-term weakness. However, the stock is still above the 60-day moving average, suggesting a longer-term bullish outlook.

**3. Technical Indicators:**

* RSI: 45.97
* PPO: -0.05
* 20-Day Relative Divergence: -4.9 (Short-term downtrend)

The RSI is in neutral territory, suggesting neither overbought nor oversold conditions. The PPO is slightly negative, indicating a possible slowdown in momentum.  The recent decline in the relative divergence is a short-term negative signal, suggesting potential for further downward movement in the near future. 

The expected return of 53.31% indicates a strong potential for long-term growth for UNH, exceeding the expected return of the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2024-08-09 | 4.58 | 98.86 B$ |
| 2024-05-09 | -1.53 | 99.80 B$ |
| 2023-11-06 | 6.31 | 92.36 B$ |
| 2024-11-04 | 6.31 | 92.36 B$ |

UNH has consistently exceeded analysts' expectations in recent quarters, demonstrating strong growth.  The company's revenue continues to increase, driven by its large market share and expansion into new markets. This growth trajectory, coupled with the strong financials and positive outlook, positions UNH for continued success in the future.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30 | $99.18B | 21.56% |
| 2024-06-30 | $97.86B | 21.52% |
| 2024-03-31 | $98.78B | 22.26% |
| 2023-12-31 | $93.25B | 22.33% |
| 2023-09-30 | $91.36B | 24.51% |

UNH continues to demonstrate solid profitability and growth in revenue. The profit margin remains consistently high, indicating efficient operations and strong pricing power.

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $94.53B | 6.41% |
| 2024-06-30 | $89.36B | 4.72% |
| 2024-03-31 | $86.69B | -1.63% |
| 2023-12-31 | $88.76B | 6.15% |
| 2023-09-30 | $84.49B | 6.91% |

The company maintains a strong capital position with solid equity levels.  The ROE has remained relatively consistent, indicating efficient capital management. 

**6. News and Recent Issues:**

* **Recent Earnings Release:**  The recent earnings release for the quarter ending September 30, 2024 was positive. UNH exceeded analysts' expectations with strong revenue and profit margins.  This news was generally well received by analysts, who reiterated their bullish recommendations. 
* **Market Outlook:**  Analysts are optimistic about UNH's future, citing its strong market position, consistent growth, and increasing demand for health insurance services. UNH's continued expansion into new markets and investments in technology are expected to drive future growth.
* **Analyst Opinions:**  Most analysts maintain a "Buy" or "Strong Buy" rating on UNH, highlighting its strong fundamentals, consistent growth, and potential for long-term success. 

**7. Overall Analysis:**

UnitedHealth Group (UNH) is a strong performer in the healthcare sector. The company has a solid track record of growth, profitability, and outperformance against the S&P 500. UNH's strong financial position, consistent earnings, and optimistic market outlook make it a strong candidate for long-term investment. While the recent short-term technical indicators suggest some potential downside risk, the long-term outlook for UNH remains positive. 
